US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRI BIO INC

1.82

-0.1300-6.67%

Post-market: 1.880.0600+3.30%19:59 EDT

Volume:243.36K

Turnover:448.23K

Market Cap:3.90M

PE:-0.03

High:2.01

Open:2.00

Low:1.72

Close:1.95

Loading ...

Overview Company News Filings

Jefferies Reaffirms Their Buy Rating on Grainger (GRI)

BRIEF-GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)

GRI Bio Inc - Topline Results From Phase 2a Study Expected in Q3 2025

THOMSON REUTERS

GRI Bio Inc - GRI-0621 Demonstrated Safe and Well-Tolerated in Interim Safety Results

THOMSON REUTERS

GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“Ipf”)

THOMSON REUTERS

GRI Bio Inc. Announces Positive Interim Safety Results from Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis

GRI Bio Inc - Reports Positive 6-Week Interim Safety Results for GRI-0621

THOMSON REUTERS

GRI Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Global convergence of sustainability disclosure standards – what boards need to know

GRI Bio (GRI) Gets a Buy from Ascendiant

GRI Bio Is Maintained at Buy by Ascendiant Capital

GRI Bio Inc. Expands Share Issuance Cap to $1.76 Million Under ATM Offering Agreement

BRIEF-GRI Bio Inc - Phase 2A Study Results For GRI-0621 Expected In Q2 2025

GRI Bio Inc - Phase 2a Study Results for GRI-0621 Expected in Q2 2025

THOMSON REUTERS

GRI Bio Inc reports results for the quarter ended March 31 - Earnings Summary

GRI Bio Q1 EPS $(5.80) Misses $(4.11) Estimate

GRI Bio Inc. Expands Global Intellectual Property Portfolio with New Patents Granted in Europe and Japan

GRI Bio Inc - Cash Runway Expected to Fund Operations Through Q3 2025

THOMSON REUTERS

GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a Ipf Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025

THOMSON REUTERS

GRI Bio Inc expected to post a loss of $4.08 a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/GRI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","market":"US","secType":"STK","nameCN":"GRI BIO INC","latestPrice":1.82,"timestamp":1752868800000,"preClose":1.95,"halted":0,"volume":243356,"hourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.82,"latestTime":"19:59 EDT","volume":3551,"amount":6535.7716,"timestamp":1752883174113},"delay":0,"floatShares":2140900,"shares":2141473,"eps":-55.205753,"marketStatus":"Market Closed","change":-0.13,"latestTime":"07-18 16:00:00 EDT","open":2,"high":2.01,"low":1.72,"amount":448227.2684548,"amplitude":0.148718,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-55.205753,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"RDOG","executeDate":"2020-01-02"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.95,"sharesOutstanding":1100000,"nav":47.93,"aum":52503274.57,"dividendRate":0.000549,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":2.01,"preClose":1.95,"latestTime":"09:24 EDT","volume":2173,"amount":4253.599694,"timestamp":1752845069246},"postHourTrading":{"tag":"盘后","latestPrice":1.88,"preClose":1.82,"latestTime":"19:59 EDT","volume":3551,"amount":6535.7716,"timestamp":1752883174113},"volumeRatio":1.1165583530941388},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRI\",,,,,undefined,":{"symbol":"GRI","floatShares":2140900,"roa":"-136.04%","roe":"-467.95%","lyrEps":-55.205753,"volumeRatio":1.1165583530941388,"shares":2141473,"dividePrice":0.001,"high":2.01,"amplitude":0.148718,"preClose":1.95,"low":1.72,"week52Low":1.1,"pbRate":"3.23","week52High":43.69,"institutionHeld":0,"latestPrice":1.82,"eps":-55.205753,"divideRate":0.000549,"volume":243356,"delay":0,"ttmEps":-55.205753,"open":2,"prevYearClose":14.0828,"prevWeekClose":1.66,"prevMonthClose":1.29,"prevQuarterClose":1.29,"fiveDayClose":1.66,"twentyDayClose":1.4,"sixtyDayClose":1.45},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550327697","title":"Jefferies Reaffirms Their Buy Rating on Grainger (GRI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2550327697","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550327697?lang=en_us&edition=fundamental","pubTime":"2025-07-10 13:35","pubTimestamp":1752125732,"startTime":"0","endTime":"0","summary":"In a report released today, Sarim Chaudhry from Jefferies maintained a Buy rating on Grainger. The company’s shares closed yesterday at p208.50. Ch...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-grainger-gri-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-reaffirms-their-buy-rating-on-grainger-gri-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRI"],"gpt_icon":0},{"id":"2548001924","title":"BRIEF-GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548001924","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548001924?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:54","pubTimestamp":1751374475,"startTime":"0","endTime":"0","summary":"BRIEF-GRI Bio Completes Enrollment In Phase 2A Study Of GRI-0621 For The Treatment Of Idiopathic Pulmonary Fibrosis (“IPF”)July 1 (Reuters) - GRI Bio Inc GRI.O:GRI BIO COMPLETES ENROLLMENT IN PHASE 2A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA3TKQYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2548382001","title":"GRI Bio Inc - Topline Results From Phase 2a Study Expected in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548382001?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:45","pubTimestamp":1751373900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA3TKQYN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2548013390","title":"GRI Bio Inc - GRI-0621 Demonstrated Safe and Well-Tolerated in Interim Safety Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2548013390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548013390?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:45","pubTimestamp":1751373900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA3TKQYN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","GRI"],"gpt_icon":0},{"id":"2548001894","title":"GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“Ipf”)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548001894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548001894?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:45","pubTimestamp":1751373900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA3TKQYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2546560780","title":"GRI Bio Inc. Announces Positive Interim Safety Results from Phase 2a Study of GRI-0621 for Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2546560780","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546560780?lang=en_us&edition=fundamental","pubTime":"2025-06-26 20:01","pubTimestamp":1750939308,"startTime":"0","endTime":"0","summary":"GRI Bio Inc. has announced positive interim safety results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis . The Independent Data Monitoring Committee has recommended the continuation of the study as no safety concerns were identified in the interim analysis of the first 24 patients. GRI-0621, a small molecule RAR-β dual agonist, is being investigated for its potential to inhibit Type 1 Invariant NKT cells, which may play a role in fibrotic diseases. Interim biomarker data from the study are expected in July 2025, with topline results anticipated in the third quarter of 2025. Currently, only two approved drugs for IPF exist, both with significant side effects and limited impact on patient survival.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nNDL8Sq8HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2546805897","title":"GRI Bio Inc - Reports Positive 6-Week Interim Safety Results for GRI-0621","url":"https://stock-news.laohu8.com/highlight/detail?id=2546805897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546805897?lang=en_us&edition=fundamental","pubTime":"2025-06-26 20:01","pubTimestamp":1750939264,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250626:nFWN3ST07B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2542586262","title":"GRI Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2542586262","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542586262?lang=en_us&edition=fundamental","pubTime":"2025-06-11 19:18","pubTimestamp":1749640680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2025 07:18 ET (11:18 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2542238267","title":"Global convergence of sustainability disclosure standards – what boards need to know","url":"https://stock-news.laohu8.com/highlight/detail?id=2542238267","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542238267?lang=en_us&edition=fundamental","pubTime":"2025-06-09 12:45","pubTimestamp":1749444308,"startTime":"0","endTime":"0","summary":"Board directors face new challenges and opportunities in navigating mandatory ESG disclosures, ensuring transparency, and driving long-term value for their companies","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/companies-markets/global-convergence-sustainability-disclosure-standards-what-boards-need-know","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/companies-markets/global-convergence-sustainability-disclosure-standards-what-boards-need-know","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["SID","ESG","BK4006","BK4139","BK4007","BK4156","GRI"],"gpt_icon":0},{"id":"2539234657","title":"GRI Bio (GRI) Gets a Buy from Ascendiant","url":"https://stock-news.laohu8.com/highlight/detail?id=2539234657","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539234657?lang=en_us&edition=fundamental","pubTime":"2025-05-29 15:55","pubTimestamp":1748505328,"startTime":"0","endTime":"0","summary":"Ascendiant analyst Edward Woo maintained a Buy rating on GRI Bio (GRI – Research Report) on May 27. The company’s shares closed yesterday at $1.35....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gri-bio-gri-gets-a-buy-from-ascendiant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gri-bio-gri-gets-a-buy-from-ascendiant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRI","BK4007"],"gpt_icon":0},{"id":"2538504844","title":"GRI Bio Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2538504844","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538504844?lang=en_us&edition=fundamental","pubTime":"2025-05-27 18:33","pubTimestamp":1748341980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2025 06:33 ET (10:33 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2537133103","title":"GRI Bio Inc. Expands Share Issuance Cap to $1.76 Million Under ATM Offering Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2537133103","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537133103?lang=en_us&edition=fundamental","pubTime":"2025-05-23 19:17","pubTimestamp":1747999044,"startTime":"0","endTime":"0","summary":"Gri Bio Inc. has announced an increase in the number of shares available for issuance under its At The Market Offering Agreement with H.C. Wainwright & Co., LLC. The company has filed a prospectus supplement to raise the maximum number of shares of its common stock, with a par value of $0.0001 per share. The new aggregate total of shares available for issuance is valued at up to $1,758,934. This is in addition to shares already sold under the agreement, which have an aggregate gross sales price of approximately $4,546,137. Legal opinions regarding the issuance and sale of these shares have been provided by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gri Bio Inc. published the origi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL7YV56w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2537946759","title":"BRIEF-GRI Bio Inc - Phase 2A Study Results For GRI-0621 Expected In Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537946759","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537946759?lang=en_us&edition=fundamental","pubTime":"2025-05-22 20:33","pubTimestamp":1747917224,"startTime":"0","endTime":"0","summary":"BRIEF-GRI Bio Inc - Phase 2A Study Results For GRI-0621 Expected In Q2 2025May 22 (Reuters) - GRI Bio Inc GRI.O:GRI BIO INC - PHASE 2A STUDY RESULTS FOR GRI-0621 EXPECTED IN Q2 2025Source text: ID:nGNXbFByd6Further company coverage: GRI.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nFWN3RU04T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2537945711","title":"GRI Bio Inc - Phase 2a Study Results for GRI-0621 Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537945711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537945711?lang=en_us&edition=fundamental","pubTime":"2025-05-22 20:07","pubTimestamp":1747915671,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nFWN3RU04T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","GRI"],"gpt_icon":0},{"id":"2535028825","title":"GRI Bio Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535028825","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535028825?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:32","pubTimestamp":1747315971,"startTime":"0","endTime":"0","summary":"GRI Bio Inc reports results for the quarter ended March 31 - Earnings SummaryGRI Bio Inc GRI.OQ reported a quarterly adjusted loss of $5.80 per share for the quarter ended March 31.  The lone analyst ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN1O9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2535840278","title":"GRI Bio Q1 EPS $(5.80) Misses $(4.11) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535840278","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535840278?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:47","pubTimestamp":1747313274,"startTime":"0","endTime":"0","summary":"GRI Bio (NASDAQ:GRI) reported quarterly losses of $(5.80) per share which missed the analyst consensus estimate of $(4.11) by 41.12 percent. This is a 94.26 percent increase over losses of $(101.05) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45435684/gri-bio-q1-eps-5-80-misses-4-11-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0},{"id":"2535684085","title":"GRI Bio Inc. Expands Global Intellectual Property Portfolio with New Patents Granted in Europe and Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2535684085","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535684085?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:36","pubTimestamp":1747312604,"startTime":"0","endTime":"0","summary":"GRI Bio has bolstered its global intellectual property portfolio with the granting of patents in Europe and Japan. This development strengthens the company's position in advancing its innovative pipeline of therapies. The new patents are expected to support the company's ongoing clinical programs and enhance its potential for future growth in the international market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gri Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL28npMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI","BK4007","BK4139"],"gpt_icon":0},{"id":"2535408338","title":"GRI Bio Inc - Cash Runway Expected to Fund Operations Through Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535408338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535408338?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:35","pubTimestamp":1747312500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nPLXE05F42:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRI","BK4139","BK4007"],"gpt_icon":0},{"id":"2535847018","title":"GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a Ipf Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535847018","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535847018?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:35","pubTimestamp":1747312500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA7J8DGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GRI","BK4139"],"gpt_icon":0},{"id":"2534436647","title":"GRI Bio Inc  expected to post a loss of $4.08 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534436647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534436647?lang=en_us&edition=fundamental","pubTime":"2025-05-09 22:42","pubTimestamp":1746801725,"startTime":"0","endTime":"0","summary":"GRI Bio Inc  expected to post a loss of $4.08 a share - Earnings Preview GRI Bio Inc GRI.OQ GRI.O is expected to report resultson May 12 (estimated) for the period ending March 31 2025LSEG's mean anal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH29B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRI"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":76,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"GRI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-5.8},{"market":"US","date":"2025-03-17","symbol":"GRI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-02-24","symbol":"GRI","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":17,"toFactor":1,"ratio":17},{"market":"US","date":"2024-11-14","symbol":"GRI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2024-08-14","symbol":"GRI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRI\",market:\"US\",,,undefined,":[{"executeDate":"2017-06-21","recordDate":null,"paymentDate":null,"value":0.35098,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":null,"paymentDate":null,"value":0.3314,"currency":"USD"},{"executeDate":"2018-03-22","recordDate":null,"paymentDate":null,"value":0.21998,"currency":"USD"},{"executeDate":"2018-06-21","recordDate":null,"paymentDate":null,"value":0.43792,"currency":"USD"},{"executeDate":"2018-09-20","recordDate":null,"paymentDate":null,"value":0.22115,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1733803200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRI","date":"2025-07-18","current":-0.519833,"percent":0.266304,"low":-67.389471,"twenty":-0.748788,"median":-0.292486,"eighty":-0.09666,"high":-0.026053,"avg":-0.944344,"sd":3.218963,"marketCap":4868760},"quantilePoints":[{"date":"2023-04-28","current":-6.452842,"twenty":-43.014819,"median":-6.452842,"eighty":-5.86271,"marketCap":20758792},{"date":"2023-05-05","current":-6.462034,"twenty":-6.958407,"median":-6.590723,"eighty":-6.414235,"marketCap":20788363},{"date":"2023-05-12","current":-6.241424,"twenty":-6.746989,"median":-6.452842,"eighty":-6.208332,"marketCap":20078661},{"date":"2023-05-19","current":-5.533634,"twenty":-6.616461,"median":-6.31496,"eighty":-5.658793,"marketCap":17801699},{"date":"2023-05-26","current":-5.561302,"twenty":-6.458357,"median":-6.186271,"eighty":-5.598088,"marketCap":17890708},{"date":"2023-06-02","current":-5.262646,"twenty":-6.452842,"median":-5.82778,"eighty":-5.482158,"marketCap":16929933},{"date":"2023-06-09","current":-5.525778,"twenty":-6.449165,"median":-5.749648,"eighty":-5.42597,"marketCap":17776429},{"date":"2023-06-16","current":-5.552999,"twenty":-6.425266,"median":-5.726667,"eighty":-5.42597,"marketCap":17863998},{"date":"2023-06-23","current":-5.27172,"twenty":-6.388497,"median":-5.639618,"eighty":-5.389675,"marketCap":16959122},{"date":"2023-06-30","current":-3.937911,"twenty":-6.292899,"median":-5.570402,"eighty":-5.286238,"marketCap":12668260},{"date":"2023-07-07","current":-3.937911,"twenty":-6.252454,"median":-5.552999,"eighty":-5.259017,"marketCap":12668260},{"date":"2023-07-14","current":-2.385349,"twenty":-6.208332,"median":-5.497533,"eighty":-4.422437,"marketCap":12084177},{"date":"2023-07-21","current":-2.080028,"twenty":-6.169725,"median":-5.444117,"eighty":-3.992352,"marketCap":10537423},{"date":"2023-07-28","current":-2.074266,"twenty":-6.062039,"median":-5.398749,"eighty":-2.492577,"marketCap":10508234},{"date":"2023-08-04","current":-2.016648,"twenty":-5.895709,"median":-5.29894,"eighty":-2.286879,"marketCap":10216339},{"date":"2023-08-11","current":-1.670937,"twenty":-5.80594,"median":-5.269392,"eighty":-2.115752,"marketCap":8464966},{"date":"2023-08-18","current":-0.705381,"twenty":-5.784454,"median":-5.253573,"eighty":-2.071731,"marketCap":8123173},{"date":"2023-08-25","current":-0.379941,"twenty":-5.775512,"median":-4.672867,"eighty":-2.016648,"marketCap":4375403},{"date":"2023-09-01","current":-0.326031,"twenty":-5.745051,"median":-4.137529,"eighty":-1.921001,"marketCap":3754569},{"date":"2023-09-08","current":-0.3029,"twenty":-5.7189,"median":-4.028646,"eighty":-1.605021,"marketCap":3488202},{"date":"2023-09-15","current":-0.344001,"twenty":-5.680197,"median":-3.282658,"eighty":-0.71008,"marketCap":3961514},{"date":"2023-09-22","current":-0.388926,"twenty":-5.612229,"median":-2.48912,"eighty":-0.572479,"marketCap":4478876},{"date":"2023-09-29","current":-0.427434,"twenty":-5.570848,"median":-2.355128,"eighty":-0.40895,"marketCap":4922329},{"date":"2023-10-06","current":-0.431285,"twenty":-5.566762,"median":-2.183742,"eighty":-0.40818,"marketCap":4966674},{"date":"2023-10-13","current":-0.385076,"twenty":-5.557981,"median":-2.111719,"eighty":-0.394317,"marketCap":4434531},{"date":"2023-10-20","current":-0.30806,"twenty":-5.545253,"median":-2.080028,"eighty":-0.388156,"marketCap":3547624},{"date":"2023-10-27","current":-0.29009,"twenty":-5.537507,"median":-2.074266,"eighty":-0.385076,"marketCap":3340680},{"date":"2023-11-03","current":-0.313195,"twenty":-5.527349,"median":-2.035374,"eighty":-0.378144,"marketCap":3606751},{"date":"2023-11-10","current":-0.326031,"twenty":-5.480587,"median":-2.016648,"eighty":-0.338353,"marketCap":3754569},{"date":"2023-11-17","current":-0.236451,"twenty":-5.463669,"median":-1.982077,"eighty":-0.328085,"marketCap":3145265},{"date":"2023-11-24","current":-0.183038,"twenty":-5.451376,"median":-1.754484,"eighty":-0.323726,"marketCap":2434765},{"date":"2023-12-01","current":-0.149115,"twenty":-5.430507,"median":-1.596033,"eighty":-0.313195,"marketCap":1983522},{"date":"2023-12-08","current":-0.135594,"twenty":-5.413267,"median":-1.130208,"eighty":-0.310628,"marketCap":1803674},{"date":"2023-12-15","current":-0.104697,"twenty":-5.396934,"median":-0.705381,"eighty":-0.306725,"marketCap":1392685},{"date":"2023-12-22","current":-0.090567,"twenty":-5.373343,"median":-0.587882,"eighty":-0.302916,"marketCap":1204721},{"date":"2023-12-29","current":-0.094904,"twenty":-5.349752,"median":-0.438986,"eighty":-0.2983,"marketCap":1262416},{"date":"2024-01-05","current":-0.110474,"twenty":-5.311643,"median":-0.435136,"eighty":-0.294711,"marketCap":1469527},{"date":"2024-01-12","current":-0.109217,"twenty":-5.291682,"median":-0.427434,"eighty":-0.246147,"marketCap":1452802},{"date":"2024-01-19","current":-0.097153,"twenty":-5.278979,"median":-0.423583,"eighty":-0.216462,"marketCap":1292334},{"date":"2024-01-26","current":-0.094979,"twenty":-5.268926,"median":-0.399195,"eighty":-0.171402,"marketCap":1263405},{"date":"2024-02-02","current":-0.094661,"twenty":-5.264413,"median":-0.392777,"eighty":-0.137831,"marketCap":1259185},{"date":"2024-02-09","current":-0.06068,"twenty":-5.257202,"median":-0.388926,"eighty":-0.126623,"marketCap":807170},{"date":"2024-02-16","current":-0.051457,"twenty":-5.14469,"median":-0.385076,"eighty":-0.111663,"marketCap":684480},{"date":"2024-02-23","current":-0.04102,"twenty":-4.999514,"median":-0.382508,"eighty":-0.110454,"marketCap":545646},{"date":"2024-03-01","current":-0.03886,"twenty":-4.71642,"median":-0.375448,"eighty":-0.10718,"marketCap":516911},{"date":"2024-03-08","current":-0.039161,"twenty":-4.422437,"median":-0.344001,"eighty":-0.100549,"marketCap":520915},{"date":"2024-03-15","current":-0.03767,"twenty":-4.279076,"median":-0.334836,"eighty":-0.098655,"marketCap":501091},{"date":"2024-03-22","current":-0.038156,"twenty":-4.093976,"median":-0.328598,"eighty":-0.095596,"marketCap":507548},{"date":"2024-03-28","current":-0.03767,"twenty":-4.028646,"median":-0.326031,"eighty":-0.094235,"marketCap":501091},{"date":"2024-04-05","current":-0.0264,"twenty":-4.010499,"median":-0.323464,"eighty":-0.087028,"marketCap":344177},{"date":"2024-04-12","current":-0.125045,"twenty":-3.937911,"median":-0.313195,"eighty":-0.088985,"marketCap":1630208},{"date":"2024-04-19","current":-0.126859,"twenty":-3.67581,"median":-0.313195,"eighty":-0.09094,"marketCap":1653862},{"date":"2024-04-26","current":-0.105479,"twenty":-2.6009,"median":-0.310628,"eighty":-0.09277,"marketCap":1375129},{"date":"2024-05-03","current":-0.105185,"twenty":-2.49373,"median":-0.30806,"eighty":-0.094235,"marketCap":1371293},{"date":"2024-05-10","current":-0.10033,"twenty":-2.46953,"median":-0.302926,"eighty":-0.09471,"marketCap":1308002},{"date":"2024-05-17","current":-0.103221,"twenty":-2.390004,"median":-0.302913,"eighty":-0.094919,"marketCap":1318551},{"date":"2024-05-24","current":-0.122034,"twenty":-2.373261,"median":-0.297792,"eighty":-0.095113,"marketCap":1558863},{"date":"2024-05-31","current":-0.089235,"twenty":-2.324907,"median":-0.295225,"eighty":-0.094904,"marketCap":1139886},{"date":"2024-06-07","current":-0.082262,"twenty":-2.229836,"median":-0.270731,"eighty":-0.09243,"marketCap":1050809},{"date":"2024-06-14","current":-0.067369,"twenty":-2.183742,"median":-0.243952,"eighty":-0.086638,"marketCap":860576},{"date":"2024-06-21","current":-0.06046,"twenty":-2.183742,"median":-0.236451,"eighty":-0.084684,"marketCap":772312},{"date":"2024-06-28","current":-0.04364,"twenty":-2.142256,"median":-0.183038,"eighty":-0.080138,"marketCap":557458},{"date":"2024-07-05","current":-0.035685,"twenty":-2.107685,"median":-0.169273,"eighty":-0.077002,"marketCap":455838},{"date":"2024-07-12","current":-0.039549,"twenty":-2.084638,"median":-0.148382,"eighty":-0.067451,"marketCap":505197},{"date":"2024-07-19","current":-0.133962,"twenty":-2.080028,"median":-0.136425,"eighty":-0.065043,"marketCap":1711236},{"date":"2024-07-26","current":-0.250214,"twenty":-2.076571,"median":-0.134227,"eighty":-0.066114,"marketCap":3196229},{"date":"2024-08-02","current":-0.123557,"twenty":-2.070463,"median":-0.136308,"eighty":-0.067151,"marketCap":1578317},{"date":"2024-08-09","current":-0.119179,"twenty":-2.057903,"median":-0.134149,"eighty":-0.067451,"marketCap":1522398},{"date":"2024-08-16","current":-0.173723,"twenty":-2.032205,"median":-0.134188,"eighty":-0.068945,"marketCap":1438081},{"date":"2024-08-23","current":-0.180019,"twenty":-2.0178,"median":-0.137022,"eighty":-0.072461,"marketCap":1490194},{"date":"2024-08-30","current":-0.179523,"twenty":-2.016648,"median":-0.143852,"eighty":-0.075548,"marketCap":1486095},{"date":"2024-09-06","current":-0.181256,"twenty":-2.012038,"median":-0.150555,"eighty":-0.076825,"marketCap":1500441},{"date":"2024-09-13","current":-0.17772,"twenty":-1.99821,"median":-0.158633,"eighty":-0.077735,"marketCap":1471164},{"date":"2024-09-20","current":-0.155898,"twenty":-1.983229,"median":-0.162446,"eighty":-0.078438,"marketCap":1290525},{"date":"2024-09-27","current":-0.157737,"twenty":-1.921001,"median":-0.162689,"eighty":-0.07939,"marketCap":1305749},{"date":"2024-10-04","current":-0.126614,"twenty":-1.771193,"median":-0.158185,"eighty":-0.081212,"marketCap":1048113},{"date":"2024-10-11","current":-0.142706,"twenty":-1.649964,"median":-0.155898,"eighty":-0.082328,"marketCap":1181323},{"date":"2024-10-18","current":-0.205129,"twenty":-1.609516,"median":-0.156191,"eighty":-0.082669,"marketCap":1698060},{"date":"2024-10-25","current":-0.253618,"twenty":-1.58474,"median":-0.158633,"eighty":-0.083857,"marketCap":2099446},{"date":"2024-11-01","current":-0.389038,"twenty":-1.55835,"median":-0.162689,"eighty":-0.085216,"marketCap":3220459},{"date":"2024-11-08","current":-0.309533,"twenty":-1.213002,"median":-0.16573,"eighty":-0.0855,"marketCap":2562314},{"date":"2024-11-15","current":-0.834738,"twenty":-0.956624,"median":-0.168878,"eighty":-0.086051,"marketCap":6897440},{"date":"2024-11-22","current":-0.744896,"twenty":-0.798801,"median":-0.172945,"eighty":-0.087419,"marketCap":6155078},{"date":"2024-11-29","current":-0.73895,"twenty":-0.817115,"median":-0.173652,"eighty":-0.088719,"marketCap":6105945},{"date":"2024-12-06","current":-0.85409,"twenty":-0.817115,"median":-0.175474,"eighty":-0.089501,"marketCap":7057347},{"date":"2024-12-13","current":-0.864901,"twenty":-0.90556,"median":-0.177225,"eighty":-0.09094,"marketCap":7146680},{"date":"2024-12-20","current":-0.800034,"twenty":-0.862739,"median":-0.178604,"eighty":-0.092559,"marketCap":6610679},{"date":"2024-12-27","current":-0.840252,"twenty":-0.85409,"median":-0.179258,"eighty":-0.093076,"marketCap":6943000},{"date":"2025-01-03","current":-0.980582,"twenty":-0.899629,"median":-0.179576,"eighty":-0.093918,"marketCap":8102549},{"date":"2025-01-10","current":-0.824359,"twenty":-0.897162,"median":-0.179967,"eighty":-0.094448,"marketCap":6811680},{"date":"2025-01-17","current":-0.778736,"twenty":-0.894437,"median":-0.183038,"eighty":-0.094807,"marketCap":6434692},{"date":"2025-01-24","current":-0.664677,"twenty":-0.882156,"median":-0.183767,"eighty":-0.094934,"marketCap":5492224},{"date":"2025-01-31","current":-0.683272,"twenty":-0.864036,"median":-0.186432,"eighty":-0.095246,"marketCap":5645877},{"date":"2025-02-07","current":-0.51786,"twenty":-0.859279,"median":-0.188825,"eighty":-0.095801,"marketCap":4279075},{"date":"2025-02-14","current":-0.59462,"twenty":-0.851712,"median":-0.211495,"eighty":-0.096227,"marketCap":4913342},{"date":"2025-02-21","current":-0.448668,"twenty":-0.847171,"median":-0.237801,"eighty":-0.096648,"marketCap":3707340},{"date":"2025-02-28","current":-0.503678,"twenty":-0.842674,"median":-0.243952,"eighty":-0.097277,"marketCap":4161888},{"date":"2025-03-07","current":-0.417118,"twenty":-0.839149,"median":-0.250793,"eighty":-0.097785,"marketCap":3446642},{"date":"2025-03-14","current":-0.38344,"twenty":-0.834284,"median":-0.285059,"eighty":-0.097973,"marketCap":3146894},{"date":"2025-03-21","current":-0.529391,"twenty":-0.832468,"median":-0.291725,"eighty":-0.098547,"marketCap":4344710},{"date":"2025-03-28","current":-0.279508,"twenty":-0.831517,"median":-0.292657,"eighty":-0.098601,"marketCap":2293923},{"date":"2025-04-04","current":-0.09666,"twenty":-0.827041,"median":-0.290527,"eighty":-0.098547,"marketCap":793290},{"date":"2025-04-11","current":-0.085138,"twenty":-0.823818,"median":-0.279508,"eighty":-0.096759,"marketCap":698726},{"date":"2025-04-17","current":-0.09666,"twenty":-0.821656,"median":-0.251372,"eighty":-0.09666,"marketCap":793290},{"date":"2025-04-25","current":-0.116504,"twenty":-0.814953,"median":-0.245324,"eighty":-0.09666,"marketCap":956151},{"date":"2025-05-02","current":-0.134428,"twenty":-0.809764,"median":-0.239152,"eighty":-0.09666,"marketCap":1103251},{"date":"2025-05-09","current":-0.0941,"twenty":-0.808683,"median":-0.211495,"eighty":-0.09666,"marketCap":772276},{"date":"2025-05-16","current":-0.084138,"twenty":-0.800034,"median":-0.204843,"eighty":-0.096031,"marketCap":788037},{"date":"2025-05-23","current":-0.070115,"twenty":-0.798953,"median":-0.187157,"eighty":-0.094904,"marketCap":656697},{"date":"2025-05-30","current":-0.343344,"twenty":-0.795147,"median":-0.196834,"eighty":-0.094964,"marketCap":3215762},{"date":"2025-06-06","current":-0.358381,"twenty":-0.793245,"median":-0.205801,"eighty":-0.0953,"marketCap":3356598},{"date":"2025-06-13","current":-0.350863,"twenty":-0.792574,"median":-0.237801,"eighty":-0.095594,"marketCap":3286180},{"date":"2025-06-20","current":-0.350863,"twenty":-0.79052,"median":-0.242668,"eighty":-0.095877,"marketCap":3286180},{"date":"2025-06-27","current":-0.320789,"twenty":-0.782931,"median":-0.250214,"eighty":-0.096326,"marketCap":3004508},{"date":"2025-07-03","current":-0.360887,"twenty":-0.772292,"median":-0.253618,"eighty":-0.096577,"marketCap":3380071},{"date":"2025-07-11","current":-0.395974,"twenty":-0.758129,"median":-0.287575,"eighty":-0.09666,"marketCap":3708689},{"date":"2025-07-18","current":-0.519833,"twenty":-0.748788,"median":-0.292486,"eighty":-0.09666,"marketCap":4868760}],"updateTime":1752988730477}}}